OPTIMIZATION OF CONSERVATIVE THERAPY OF UTERINE LEIOMYOMA WITH ANTIPROGESTERONS AND ASSESSMENT OF THE THERAPY'S INFLUENCE ON WOMEN QUALITY OF LIFE
There are the results of six-month using of the medication Gynestril (in a dose of 12,5 mg once a day) within women with uterine leiomyoma both of reproductive age and premenopausal age. It was determined that this medication puts a stay on the tumor growth and improves women quality of life.